HomeQuestion
In light of recent data from ASCO 2019 and the NEJM, would you recommend induction chemotherapy or an adjuvant approach in combination with chemoradiation for locally advanced nasopharyngeal carcinoma?
1
1 Answers
Mednet Member
Medical Oncology · Florida Cancer Specialists
Definitely, and yes mainly for EBV positive tumors.
That trial certainly provides not only rationale for using induction Cis-Gemcitabine, but also the little role left of adjuvant therapy.